Related Experiment Video
Updated: Jan 29, 2026

Ammonia Synthesis at Low Pressure
Published on: August 23, 2017
Hepatic glutamine synthetase augmentation enhances ammonia detoxification
Leandro R Soria1, Matthew Nitzahn2,3, Angela De Angelis1
1Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Overexpressing liver glutamine synthetase (GS) effectively reduces high blood ammonia levels in mice. This approach shows promise for treating hyperammonemia, a condition caused by waste nitrogen removal pathway deficiencies.
Area of Science:
- Biochemistry
- Genetics
- Hepatology
Background:
- Deficiencies in the urea cycle and glutamine synthetase (GS) lead to hyperammonemia.
- Effective therapies for hyperammonemia are crucial for managing waste nitrogen removal disorders.
Purpose of the Study:
- To investigate the therapeutic potential of liver-specific GS overexpression for hyperammonemia.
- To evaluate the efficacy of a helper-dependent adenoviral (HDAd) vector for hepatic GS delivery.
Main Methods:
- Generated an HDAd vector (HDAd-GS) for liver-specific murine GS expression.
- Administered HDAd-GS to wild-type and carbamoyl phosphate synthetase 1 (Cps1)-deficient mice.
- Assessed blood ammonia, glutamine, and urea levels following ammonia challenges.
Main Results:
- HDAd-GS administration reduced blood ammonia levels in wild-type mice.
- Increased hepatic GS led to higher blood glutamine and unaffected blood urea.
- HDAd-GS protected Cps1-deficient mice against acute hyperammonemia.
Conclusions:
- Upregulation of hepatic GS is effective in reducing hyperammonemia.
- Liver-specific GS augmentation demonstrates potential for treating primary and secondary hyperammonemia.
- GS plays a critical role in ammonia detoxification.
Related Concept Videos
Preparation of Amines: Alkylation of Ammonia and Amines
Each alkylation step makes the nitrogen center more nucleophilic, which triggers successive alkylations until a quaternary ammonium salt is formed. Considering...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Self-Evaluation: Self-Enhancement and Self-Verification
Reduction of Alkynes to trans-Alkenes: Sodium in Liquid Ammonia
When dissolved in liquid ammonia, an alkali metal, such as sodium,...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

